Delivery Order SPE2DB24D2217-SPE2DB25FJXVV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,247.90 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on July 16, 2025, with completion scheduled for July 17, 2025. This competitive, non-set-aside delivery order represents a firm fixed-price transaction for pharmaceutical supply. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $58,252.86 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) under a firm fixed price contract. The order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $53,049.32 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on April 21, 2025, with an ultimate completion date of April 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order valued at $3,258.15 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction within AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $40,900.74 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on September 16, 2025, with an ultimate completion date of September 17, 2025. The award was made on a competitive, non-set-aside basis under a firm fixed-price contract structure. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,544.19 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) with a firm fixed price structure. This non-set-aside contract was competitively awarded and is scheduled for completion by September 29, 2025. The order will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a $1,589.62 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count package). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $4,771.95 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on July 29, 2025, with completion scheduled for July 30, 2025. This non-competitive delivery order represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $25,277.89 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 9, 2025, with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $3,107.17 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on June 2, 2025, with an ultimate completion date of June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- SPE2DB24D2217Indefinite Delivery Contract
- SPE2DB24D2217-SPE2DB25FJXVVDelivery Order
The Defense Logistics Agency (DLA) awarded a $42,420.50 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical supply delivery to support military healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor specializing in brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle enables comprehensive global pharmaceutical support for military healthcare programs, allowing the company to supply a broad range of specialty medications and medical commodities to customers including the Defense Health Agency and U.S. Coast Guard. The award reflects AmerisourceBergen Drug Corp's demonstrated capability to meet federal procurement requirements through competitive award processes and its significant role in supporting the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.4k | 9/25/25 |